Verona Pharma plc (VRNA) Reports In-Line Q3 EPS

Verona Pharma plc (NASDAQ: VRNA) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07).

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• XORTX to voluntarily delist from TSX Venture Exchange
• Nvidia pitches Vera CPU to Chinese clients with August delivery target